These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Tumor cell-specific transgene expression prevents liver toxicity of the adeno-HSVtk/GCV approach. Brand K; Löser P; Arnold W; Bartels T; Strauss M Gene Ther; 1998 Oct; 5(10):1363-71. PubMed ID: 9930342 [TBL] [Abstract][Full Text] [Related]
30. Antitumoral effect of interleukin-12-secreting fibroblasts in a mouse model of ovarian cancer: implications for the use of ovarian cancer biopsy-derived fibroblasts as a vehicle for regional gene therapy. Sanches R; Kuiper M; Penault-Llorca F; Aunoble B; D'Incan C; Bignon YJ Cancer Gene Ther; 2000 May; 7(5):707-20. PubMed ID: 10830718 [TBL] [Abstract][Full Text] [Related]
31. Combined adenovirus-mediated nitroreductase gene delivery and CB1954 treatment: a well-tolerated therapy for established solid tumors. Djeha AH; Thomson TA; Leung H; Searle PF; Young LS; Kerr DJ; Harris PA; Mountain A; Wrighton CJ Mol Ther; 2001 Feb; 3(2):233-40. PubMed ID: 11237680 [TBL] [Abstract][Full Text] [Related]
32. Interleukin-12 inhibits liver-specific drug-inducible systems in vivo. Reboredo M; Zabala M; Mauleon I; De Las Rivas J; Kreppel F; Kochanek S; Prieto J; Hernandez-Alcoceba R; Kramer MG Gene Ther; 2008 Feb; 15(4):277-88. PubMed ID: 18033307 [TBL] [Abstract][Full Text] [Related]
33. Attenuation of the glucocorticoid response during Ad5IL-12 adenovirus vector treatment enhances natural killer cell-mediated killing of MHC class I-negative LNCaP prostate tumors. Raja Gabaglia C; Diaz de Durana Y; Graham FL; Gauldie J; Sercarz EE; Braciak TA Cancer Res; 2007 Mar; 67(5):2290-7. PubMed ID: 17332360 [TBL] [Abstract][Full Text] [Related]
34. Thyroid cancer immuno-therapy with retroviral and adenoviral vectors expressing granulocyte macrophage colony stimulating factor and interleukin-12 in a rat model. Tanaka K; Towata S; Nakao K; Mizuguchi H; Hayakawa T; Niwa M; Ishii N; Nagayama Y Clin Endocrinol (Oxf); 2003 Dec; 59(6):734-42. PubMed ID: 14974915 [TBL] [Abstract][Full Text] [Related]
35. Augmentation of local antitumor immunity in the liver by tumor vaccine modified to secrete murine interleukin 12. Fuji N; Fujiwara H; Ueda Y; Taniguchi F; Yoshimura T; Oka T; Yamagishi H Gene Ther; 1999 Jun; 6(6):1120-7. PubMed ID: 10455415 [TBL] [Abstract][Full Text] [Related]
36. Combination therapy of S-1 with selective cyclooxygenase-2 inhibitor for liver metastasis of colorectal carcinoma. Tachimori A; Yamada N; Amano R; Ohira M; Hirakawa K Anticancer Res; 2008; 28(2A):629-38. PubMed ID: 18507001 [TBL] [Abstract][Full Text] [Related]
37. The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status. Douin-Echinard V; Bornes S; Rochaix P; Tilkin AF; Peron JM; Bonnet J; Favre G; Couderc B Cancer Gene Ther; 2000 Dec; 7(12):1543-56. PubMed ID: 11228533 [TBL] [Abstract][Full Text] [Related]
38. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity. Wildner O; Morris JC Cancer Res; 2000 Aug; 60(15):4167-74. PubMed ID: 10945625 [TBL] [Abstract][Full Text] [Related]
39. Antitumor mechanism of intratumoral injection with IL-12-expressing adenoviral vector against IL-12-unresponsive tumor. Kanagawa N; Gao JQ; Motomura Y; Yanagawa T; Mukai Y; Yoshioka Y; Okada N; Nakagawa S Biochem Biophys Res Commun; 2008 Aug; 372(4):821-5. PubMed ID: 18519033 [TBL] [Abstract][Full Text] [Related]
40. [Gene therapy and liver metastases]. Martinet O; Reis ED; Gillet M Schweiz Med Wochenschr; 1999 Aug; 129(34):1187-95. PubMed ID: 10486858 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]